Coronary Artery Disease Clinical Trials in Ann Arbor, Michigan

5 studies are recruiting for coronary artery disease in Ann Arbor, Michigan right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Product Surveillance Registry

    The purpose of the Registry is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products. The Registry data is intended to benefit and support interests of patients, hospitals, clinicians, regulatory bodies, payers, and industry by str…

    Stage
    Not phased
    Ages
    Any age
    Site
    Research site, Ann Arbor, Michigan
    Locations
    401 in total
    Run by
    Medtronic

    See if you can join NCT01524276 on ClinicalTrials.gov

  2. CTSN Embolic Protection Trial

    This is a prospective, multi-center, randomized effectiveness trial of the CardioGard Embolic Protection Cannula in high-risk valve surgery patients.

    Stage
    Not phased
    Ages
    60 and older
    Site
    University of Michigan, Ann Arbor, Michigan
    Locations
    28 in total
    Run by
    Icahn School of Medicine at Mount Sinai

    See if you can join NCT06027788 on ClinicalTrials.gov

  3. Prevail Global Study

    The purpose of the study is to evaluate the clinical safety and efficacy of the Prevail DCB.

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of Michigan Health System - University Hospital, Ann Arbor, Michigan
    Locations
    51 in total
    Run by
    Medtronic Vascular

    See if you can join NCT06535854 on ClinicalTrials.gov

  4. Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women

    The central hypothesis of ROMA:Women is that the use of multiple arterial grafting (MAG) will improve clinical outcomes and quality of life (QOL) compared to single arterial grafting (SAG). The specific aims of ROMA:Women are: Aim 1: Determine the impact of MAG vs SAG on major adverse cardiac and c…

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of Michigan, Ann Arbor, Michigan
    Locations
    146 in total
    Run by
    Weill Medical College of Cornell University

    See if you can join NCT04124120 on ClinicalTrials.gov

  5. Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease

    COMPLETE-2 is a prospective, multi-centre, randomized controlled trial comparing a strategy of physiology-guided complete revascularization to angiography-guided complete revascularization in patients with acute ST-segment elevation myocardial infarction (STEMI) or non-ST-segment elevation myocardi…

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of Michigan, Ann Arbor, Michigan
    Locations
    113 in total
    Run by
    Population Health Research Institute

    See if you can join NCT05701358 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.